Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP001151

Drug Information
NameDesipramine    
SynonymsPrestwick1_000343; Sertofran; AC-15977; 5-(gamma-Methylaminopropyl)iminodibenzyl; 5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N-methyl-; KBio2_006057; DMI 50475; 10, 11-Dihydro-N-methyl-5H-dibez[b,f]azepine-5-propanamine; Desipramine (INN); Dimethylimipramine; desipraminum; Prestwick2_000343; KBioSS_000921; 50-47-5; Spectrum_000441; CHEBI:47781; Desimipramine; AB00053450; KBio1_000190; DivK1c_000190; KBio2_000921; Desipraminum [INN-Latin]; Desipramin; Lopac0_000358; Spectrum5_000833; Monodemethylimipramine; KBio3_001357; KBio2_003489; EINECS 200-040-0; Methylaminopropyliminodibenzyl; DMI (pharmaceutical); Lopac-D-3900; (3-(10H,11H-Dibenzo[b,f]azepin-5-yl)propyl)methylamine; 5H-Dibenz[b,f]azepine-5-propanamine, 10,11-dihydro-N-methyl-; Demethylimipramine; UNII-TG537D343B; Desipramina [INN-Spanish]; DB01151; D07791; Dezipramine; 3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N-methylpropan-1-amine; MolPort-002-051-955; Prestwick0_000343; Norimipramine; L001089; BRN 1432747; NCGC00015340-10; ZERO/006017; BSPBio_002137; C06943; BPBio1_000447; N-(3-Methylaminopropyl)iminobibenzyl; CHEMBL72; Spectrum2_000091; NCGC00015340-01; BSPBio_000405; NCGC00024375-04; Pertrofane; 5H-Dibenz(b,f)azepine, 10,11-dihydro-5-(3-(methylamino)propyl)-; NINDS_000190; STOCK2S-34822; Desipramine (D4); Desipramina; NCGC00015340-02; LS-60421; CCRIS 7091; SPBio_000042; SPBio_002326; KBioGR_000928; HSDB 3052; 10,11-Dihydro-5-(3-methylaminopropyl)-5H-dibenz(b,f)azepine; Norpramine; Desmethylimipramine; 5H-Dibenz[b,f]azepine-5-propanamine, 10,11-dihydro-N-methyl-; Spectrum3_000379; AC1L1EXQ; 58-28-6 (hydrochloride); desipramine; Prestwick3_000343; Spectrum4_000314; Pentofran; NCGC00015340-03; CAS-58-28-6; Imipramine, demethyl-; DB07682; Desimpramine; IDI1_000190; AKOS001681456; STK735144; Desipramine Hcl; 3-(10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N-METHYLPROPAN-1-AMINE; Desipramine [INN:BAN]; CID2995    
Trade NameNorpramin; Pertofrane    
IndicationDepressionApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAntidepressants    
CAS NumberCAS 50-47-5
FormularC18H22N2    
PubChem Compound IDCID 2995.    
PubChem Substance IDSID 9158.    
ChEBI47781;    
SuperDrug ATC IDN06AA01;    
SuperDrug CAS ID000050475;    
TargetNorepinephrine reuptakeInhibitor[2]
Ref 1Emerging treatments for depression. Expert Opin Pharmacother. 2006 Dec;7(17):2323-39. To Reference
Ref 2Augmentation effect of combination therapy of aripiprazole and antidepressants on forced swimming test in mice. Psychopharmacology (Berl). 2009 Jun 11. [Epub ahead of print] To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543